SRI's CRO cuts the ribbon on a new early-phase outpost

SRI International's in-house CRO has opened up a new Phase I center, expanding its footprint in the market for early-stage research. The new facility, in Plymouth, MI, is a 9,400-square-foot space within the Michigan Life Science Innovation Center, giving SRI Biosciences the capacity to conduct Phase I studies of new medicines and medical devices. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.